Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Perspective

Purine Nucleosides and Analogues Bearing Chiral Substituents: Medicinal Chemistry and Therapeutic Perspective

Author(s): Mikhail S. Drenichev* and Valentina N. Borokh

Volume 31, Issue 6, 2024

Published on: 23 June, 2023

Page: [671 - 682] Pages: 12

DOI: 10.2174/0929867330666230420152130

conference banner
Abstract

Adenosine and its analogues play an important role as bioregulators of metabolic processes in animal cells, affecting a variety of metabolic functions by acting through the purinergic signaling system. Synthesis and structure-activity relationship for some known purine nucleosides bearing chiral substituents are considered in this work. These compounds represent a promising potential as drug prototypes for targeted therapy of cancer, metabolic dysfunctions, and neuronal disorders due to their enhanced selectivity to receptors of the purinergic signaling system. Derivatives of adenosine and guanosine containing a chiral substituent also manifest antiviral activity.

Keywords: Adenosine receptors, purinergic signaling, adenosine, chirality, enantiomeric, antiviral, transglycosylation, enzyme.


© 2024 Bentham Science Publishers | Privacy Policy